Author: Andi Thornton
Support grows for Spinraza
TreatSMA continues to work with NICE, NHSE and Biogen. We are seeking to expand inclusion if possible based on the recent appeal and campaign that TreatSMA and the community colaborated on together. TreatSMA and the community have made ITV News and BBC News five times in the last week appealing to NICE and the NHS…
Support grows for Spinraza
TreatSMA continues to work with NICE, NHSE and Biogen. We are seeking to expand inclusion if possible based on the recent appeal and campaign that TreatSMA and the community colaborated on together. TreatSMA and the community have made ITV News and BBC News five times in the last week appealing to NICE and the NHS…
The fight goes on
After sending additional information to the stakeholders, we have now proceeded with appealing the proposed nusinersen guidance and the Managed Access Agreement.
The fight goes on
After sending additional information to the stakeholders, we have now proceeded with appealing the proposed nusinersen guidance and the Managed Access Agreement.
The SMA Community and clinicians react to draft NICE guidance
The clinicians and SMA community react to the draft nusinersen guidance
The SMA Community and clinicians react to draft NICE guidance
The clinicians and SMA community react to the draft nusinersen guidance
No update yet but please stay tuned
We are trying to find a way out of the MAA criteria, please stay tuned.
No update yet but please stay tuned
We are trying to find a way out of the MAA criteria, please stay tuned.